These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2192113)

  • 1. [Therapeutic drug monitoring of inhibitors of renin-angiotensin system].
    Saito I; Saruta T
    Nihon Rinsho; 1990 Feb; 48 Suppl():1146-8. PubMed ID: 2192113
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of 'tissue' and 'plasma' angiotensin converting enzyme inhibitors on overall haemostatic potentials in rats.
    Kramkowski K; Mogielnicki A; Chabielska E; Cylwik D; Buczko W
    Thromb Res; 2006; 117(5):557-61. PubMed ID: 15985287
    [No Abstract]   [Full Text] [Related]  

  • 3. Determination of captopril in human plasma, using solid phase extraction and high-performance liquid chromatography, coupled to mass spectrometry: application to bioequivalence study.
    Rezende KR; Mundim IM; Teixeira LS; Souza WC; Ramos DR; Cardoso CR; Souza IC; Gratão MZ; Bellório KB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):59-67. PubMed ID: 17145205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical pharmacology of ACE inhibitors].
    Hitzenberger G
    Wien Med Wochenschr; 1990 Jan; 140(1-2):12-8. PubMed ID: 2408245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril and enalapril: angiotensin-converting enzyme inhibitors.
    Allen TA; Wilke WL; Fettman MJ
    J Am Vet Med Assoc; 1987 Jan; 190(1):94-6. PubMed ID: 3028998
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of captopril in human blood by an enzyme-linked immunosorbent assay.
    Jehanli AM; Arafat T; al-Shami M
    J Pharm Pharmacol; 1996 Sep; 48(9):914-7. PubMed ID: 8910853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bradykinin and inhibition of angiotensin-converting enzyme in hypertension.
    Azizi M
    N Engl J Med; 1999 Mar; 340(12):967; author reply 968-9. PubMed ID: 10094648
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cough induced by converting enzyme inhibitors].
    Ostermann G; Freneaux E; Germain ML; Pasqual JC; Chousy H
    Therapie; 1986; 41(5):404-5. PubMed ID: 3027912
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetic profiles of single and repeat doses of lisinopril and enalapril in congestive heart failure.
    Johnston D; Duffin D
    Am J Cardiol; 1992 Oct; 70(10):151C-153C. PubMed ID: 1329474
    [No Abstract]   [Full Text] [Related]  

  • 10. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors].
    Schofer J
    Dtsch Med Wochenschr; 1988 Oct; 113(43):1684-9. PubMed ID: 2846252
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
    Westendorp B; Schoemaker RG; van Gilst WH; van Veldhuisen DJ; Buikema H
    Eur J Pharmacol; 2005 Dec; 527(1-3):141-9. PubMed ID: 16310764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic determination of enalapril in human plasma by enzyme kinetic analytical method.
    Thongnopnua P; Poeaknapo C
    J Pharm Biomed Anal; 2005 Apr; 37(4):763-9. PubMed ID: 15797799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the duration of action of angiotensin converting enzyme inhibitors affect their safety and adverse effects?
    Frank GJ
    J Hypertens Suppl; 1989 Sep; 7(5):S17-22. PubMed ID: 2553900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction.
    Coriat P; Richer C; Douraki T; Gomez C; Hendricks K; Giudicelli JF; Viars P
    Anesthesiology; 1994 Aug; 81(2):299-307. PubMed ID: 8053578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should the use of short acting angiotensin-converting enzyme inhibitors be abandoned?
    Erman A; Boner G; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2000 Dec; 1(4):365-8. PubMed ID: 11967825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cough with angiotensin converting-enzyme inhibitors.
    Hood S; Nicholls MG; Gilchrist NL
    N Z Med J; 1987 Jan; 100(816):6-7. PubMed ID: 3027630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cough caused by angiotensin-converting enzyme inhibitors. A series of cases collected by spontaneous notification of adverse reactions].
    Capellà D; Torres F; Avila P; Moreno V; Laporte JR
    Med Clin (Barc); 1991 Feb; 96(4):126-8. PubMed ID: 2023485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fetal angiotensin converting enzyme (ACE) inhibition renal failure].
    Muto R; Ohashi H
    Ryoikibetsu Shokogun Shirizu; 2001; (33):678-9. PubMed ID: 11462629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.